Align Technology shares plunged last after Q2 results were posted. They are now down some 55% from my Sell rating on the stock early in 2024. It should be noted that the company boasts a strong balance sheet with $900M in cash, no long-term debt, solid free cash flow, and a $1B buyback authorization. The CEO of the company also stepped up and purchased nearly $1M in shares after last week's decline.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Align Technology (ALGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Major U.S. equity indexes moved lower on Thursday after the latest Personal Consumption Expenditures (PCE) data showed inflation accelerated in June, offsetting strong Big Tech earnings. Several economists attributed the higher-than-expected reading for the PCE, the Federal Reserve's preferred inflation gauge, to tariff pressures.
Align Technology (ALGN) was the worst-performing stock in the S&P 500 Thursday, losing more than a third of its value a day after the Invisalign maker reported second-quarter results that missed analysts' expectations and announced a restructuring.
Align Technology tumbles 34.2% after Q2 earnings and revenues miss estimates as Clear Aligner sales drop and margins tighten further.
Align Technology, Inc. (NASDAQ:ALGN ) Q2 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants John F. Morici - CFO & Executive VP of Global Finance Joseph M.
The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Align Technology (ALGN) came out with quarterly earnings of $2.49 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $2.41 per share a year ago.
ALGN is likely to have delivered robust Q2 2025 performance as Invisalign traction and iTero upgrades gained steam across global markets.
Align Technology (ALGN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ALGN broke through the 200-day moving average, which suggests a long-term bullish trend.
From a technical perspective, Align Technology (ALGN) is looking like an interesting pick, as it just reached a key level of support. ALGN recently overtook the 20-day moving average, and this suggests a short-term bullish trend.